Stay updated on GB1275 Monotherapy and with Anti-PD1 in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the GB1275 Monotherapy and with Anti-PD1 in Solid Tumors Clinical Trial page.

Latest updates to the GB1275 Monotherapy and with Anti-PD1 in Solid Tumors Clinical Trial page
- Check4 days agoChange DetectedThe page footer now shows Revision: v3.5.5, replacing v3.5.4. This is a minor publishing update and does not affect the study details.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe revision is updated from v3.5.3 to v3.5.4, indicating a software update. No user-facing changes to study content are evident.SummaryDifference0.0%

- Check47 days agoChange DetectedThe page’s informational footer revision was updated from v3.5.2 to v3.5.3, indicating a minor platform/version change without altering the study details shown on the record.SummaryDifference0.0%

- Check54 days agoChange DetectedThe page revision was updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check68 days agoChange DetectedAdded Squamous cell carcinoma of the head and neck and Small cell lung carcinoma to the study's listed conditions.SummaryDifference0.1%

- Check83 days agoChange DetectedHepatocellular Carcinoma was added to the conditions list, and the page revision was updated to v3.5.0.SummaryDifference0.1%

Stay in the know with updates to GB1275 Monotherapy and with Anti-PD1 in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GB1275 Monotherapy and with Anti-PD1 in Solid Tumors Clinical Trial page.